NEW YORK (360Dx) – Meso Scale Diagnostic today announced it received its first clearance from the US Food and Drug Administration for an in vitro diagnostic.

The agency cleared Meso Scale's conventional C-reactive protein assay, which is based on the company's Multi-Array technology. The technology has been used in life science research applications for about 20 years. CRP is a diagnostic biomarker that has taken on importance for its applications in personalized medicine and companion diagnostics, Meso Scale said.